Yasunari Miyazaki Selected Research

Idiopathic Pulmonary Fibrosis

12/2023	A prospective cohort study of periostin as a serum biomarker in patients with idiopathic pulmonary fibrosis treated with nintedanib.
7/2023	Exploratory phase 2 study of the novel oral multi-kinase inhibitor TAS-115 in patients with idiopathic pulmonary fibrosis.
1/2023	Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy.
12/2020	Disruption in the balance between apolipoprotein A-I and mast cell chymase in chronic hypersensitivity pneumonitis.
7/2019	Periostin as a predictor of prognosis in chronic bird-related hypersensitivity pneumonitis.
11/2015	Cyclosporine A combined with low-dose corticosteroid treatment in patients with idiopathic pulmonary fibrosis.
12/2008	Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis.
3/2007	Elemental analysis of inorganic dusts in lung tissues of interstitial pneumonias.
7/2003	Cyclosporin A followed by the treatment of acute exacerbation of idiopathic pulmonary fibrosis with corticosteroid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasunari Miyazaki Research Topics

Disease

40	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 02/2024 - 05/2003
24	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2024 - 06/2002
16	Pneumonia (Pneumonitis) 03/2024 - 10/2003
15	COVID-19 01/2024 - 01/2020
11	Neoplasms (Cancer) 04/2024 - 12/2011
9	Inflammation (Inflammations) 04/2024 - 10/2003
9	Idiopathic Pulmonary Fibrosis 12/2023 - 07/2003
8	Disease Progression 03/2023 - 07/2003
8	Infections 01/2023 - 01/2008
8	Lung Diseases (Lung Disease) 01/2022 - 03/2012
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2013
7	Fibrosis (Cirrhosis) 01/2024 - 09/2007
6	Asthma (Bronchial Asthma) 04/2024 - 10/2003
6	Lung Neoplasms (Lung Cancer) 03/2024 - 02/2020
5	Bronchiectasis 07/2021 - 09/2007
4	Thrombosis (Thrombus) 01/2024 - 07/2011
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2023 - 12/2010
4	Sarcoidosis (Schaumann Disease) 01/2018 - 09/2012
4	Vascular Diseases (Vascular Disease) 12/2015 - 03/2007
3	Farmer's Lung 11/2023 - 09/2013
3	Respiratory Insufficiency (Respiratory Failure) 03/2023 - 11/2019
3	Dyspnea (Shortness of Breath) 03/2023 - 07/2011
3	Hemorrhage 01/2021 - 07/2011
2	Adenocarcinoma of Lung 02/2024 - 01/2023
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2024 - 12/2018
2	Hypersensitivity (Allergy) 11/2023 - 01/2019
2	Bird Fancier's Lung 03/2023 - 12/2008
2	Thromboembolism 01/2022 - 07/2011
2	Emphysema 04/2021 - 12/2018
2	Granuloma 01/2021 - 01/2015
2	Pneumothorax 01/2020 - 10/2010
2	Dermatomyositis (Dermatopolymyositis) 03/2012 - 06/2002
1	Respiratory Hypersensitivity 04/2024
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2024
1	Carcinogenesis 02/2024
1	Seasonal Allergic Rhinitis (Hay Fever) 11/2023
1	Mesothelioma 07/2023
1	Breast Neoplasms (Breast Cancer) 05/2023

Drug/Important Bio-Agent (IBA)

34	AntigensIBA 02/2024 - 02/2007
12	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2015
8	Proteins (Proteins, Gene)FDA Link 12/2023 - 12/2010
8	AntibodiesIBA 11/2023 - 10/2003
8	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 07/2003
7	CytokinesIBA 04/2024 - 05/2003
7	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2020
7	Immunoglobulin G (IgG)IBA 07/2023 - 10/2003
5	CollagenIBA 12/2015 - 03/2007
4	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 05/2023 - 01/2015
4	ChemokinesIBA 01/2023 - 03/2012
4	Immunoglobulin A (IgA)IBA 01/2023 - 10/2011
3	NivolumabIBA 04/2024 - 01/2020
3	Immunoglobulin E (IgE)IBA 04/2024 - 10/2003
3	favipiravirIBA 03/2023 - 01/2021
3	LigandsIBA 01/2023 - 01/2015
3	fibrin fragment D (D-dimer)IBA 06/2021 - 07/2011
3	Interleukin-17 (Interleukin 17)IBA 01/2021 - 09/2012
3	SteroidsIBA 01/2019 - 06/2002
3	OvalbuminIBA 01/2018 - 10/2003
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2015 - 06/2002
3	Messenger RNA (mRNA)IBA 09/2012 - 05/2003
2	atezolizumabIBA 04/2024 - 01/2023
2	pembrolizumabIBA 04/2024 - 02/2024
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2024 - 01/2014
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2024 - 01/2018
2	nintedanibIBA 12/2023 - 12/2018
2	PeriostinIBA 12/2023 - 07/2019
2	Immunoglobulins (Immunoglobulin)IBA 11/2023 - 07/2021
2	Tyrosine Kinase InhibitorsIBA 11/2023 - 01/2021
2	Methylcellulose (BFL)IBA 03/2023 - 12/2008
2	Oxygen (Dioxygen)IBA 01/2023 - 01/2021
2	RNA (Ribonucleic Acid)IBA 09/2022 - 01/2022
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2013
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 12/2020 - 01/2018
2	IsocyanatesIBA 09/2013 - 05/2003
2	ProteomeIBA 03/2012 - 12/2010
1	IpilimumabIBA 04/2024
1	durvalumabIBA 04/2024
1	prostaglandin D2 receptorIBA 04/2024
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2024
1	CarcinogensIBA 02/2024
1	Tobacco Smoke Pollution (Passive Smoking)IBA 02/2024
1	Docetaxel (Taxotere)FDA Link 02/2024
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2024
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2024
1	trametinibIBA 02/2024
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2024
1	Plasminogen Activator Inhibitor 1IBA 01/2024
1	Plasminogen InactivatorsIBA 01/2024
1	Ointments (Pastes)IBA 11/2023
1	Anaplastic Lymphoma KinaseIBA 11/2023
1	Phosphotransferases (Kinase)IBA 07/2023
1	4- (2- fluoro- 4- ((((2- phenylacetyl)amino)thioxomethyl)amino)phenoxy)- 7- methoxy- N- methyl- 6- quinolinecarboxamideIBA 07/2023
1	Prednisolone (Predate)FDA LinkGeneric 05/2023
1	abemaciclibIBA 05/2023

Therapy/Procedure

19	Therapeutics 04/2024 - 07/2003
5	Traction 07/2021 - 09/2007
4	Immunotherapy 02/2024 - 01/2022
4	Drug Therapy (Chemotherapy) 02/2024 - 01/2020
2	Humidifiers 11/2023 - 01/2022
2	Lung Transplantation 03/2023 - 04/2019